Iron Isomaltoside

异麦芽糖酐铁

Report date: 2026/04/30 20:00:20

Base Information

Drug NameIron Isomaltoside
Drug Alias NameFerric derisomaltoseMonoferMonoverDiaferIsofer +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIron replacements
TargetsNot applicable
Therapy Area/IndicationsIron deficiencyDeficiency DiseasesIron Metabolism Disorders +[15] 
Global Approved IndicationsAnemia, Iron-Deficiency
Approved Indications in ChinaAnemia, Iron-Deficiency
Original Approved Country/TerritoryN/A
Original Approved Date2016/11/17
Country/TerritoryUnited StatesNorwayHungary +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPharmacosmos A/S
China Registration ClassN/A

Develop Information

Active CompaniesOregon Health And Science UniversityWasserburger Arzneimittelwerk GmbhPharmacosmos A/S +[4] 
Inactive CompaniesEddingpharm (China) Co Ltd
Active IndicationsIron deficiencyAnemia, Iron-DeficiencyHeart Failure +[5] 
Inactive IndicationsDeficiency DiseasesIron Metabolism DisordersAnemia +[10] 

Other Information

ATC CodeB03AC
Related LinksDrugBankKEGG